STAT5A and acute lymphoblastic leukemia: In this study, the impact of STAT5A inhibition on B-ALL cell lines and ALL patient-derived cells were assessed by screening a library of lipid-substituted polymeric nanoparticles and determined the most effective polymeric carriers for STAT5A siRNA delivery.